Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of different doses of
XL844 when given orally to adults with recurrent or refractory chronic lymphocytic leukemia
or small lymphocytic lymphoma.